trending Market Intelligence /marketintelligence/en/news-insights/trending/bxdJXzy4A2Iecv1WRTyZhQ2 content esgSubNav
In This List

Emergent buys Sanofi's smallpox vaccine biz

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Emergent buys Sanofi's smallpox vaccine biz

Emergent BioSolutions Inc. completed the acquisition of Sanofi SA's smallpox vaccine ACAM2000, including two manufacturing facilities: one in Canton, Mass., and another in Rockville, Md.

The Maryland-based company paid $117.5 million in upfront cash and will pay a further $7.5 million once certain conditions are met.

Emergent will also assume responsibility for an existing 10-year contract valued at up to $425 million with the Centers for Disease Control and Prevention.

The contract has a remaining value of about $160 million for deliveries of ACAM2000 to the Strategic National Stockpile.